This article is authored by Dr Amit Kumar Agarwal, senior consultant, neurosciences, neurology and stroke medicine, Amrita Hospital, Faridabad.

After experiencing seizures every other week, Christine Kauzen has been seizure-free for months since receiving a rare epilepsy treatment.

Based in Mountain View, Calif., NeuroPace is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating ...

Sean Lew, recommended the responsive neurostimulation procedure or RNS. "For epilepsy surgery, traditionally, the treatment is to find the part of the brain causing seizures and removing that part ...

NeuroPace is known for its innovative RNS System, the first brain-responsive platform that provides personalized treatment to manage seizures in patients with drug-resistant epilepsy, potentially ...

NeuroPace unveiled the data as part of a series of poster presentations at the American Epilepsy Society’s annual meeting in Washington, D.C. Silicon Valley-based NeuroPace claims its RNS System ...

NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components, which include the RNS neurostimulator as ...

(NASDAQ:NPCE), a medical device company specializing in neurological disorders, has been making significant strides in the epilepsy treatment market with its Responsive Neurostimulation (RNS ...

using real-world data from children treated with RNS therapy across 27 pediatric epilepsy centers to support an expansion in indication for use; FDA submission anticipated in second half of 2025 ...

“We have several ongoing clinical programs examining the RNS System in expanded patient populations and new indications in epilepsy that are expected to announce data or have regulatory events ...

NeuroPace, Inc. (NASDAQ:NPCE), a medical device company specializing in neurological disorders, has been making significant strides in the epilepsy treatment market with its Responsive ...